New Drug Approvals Archive
Get news by email or subscribe to our news feeds.
April 2003
| April 4 |
Iprivask (desirudin) InjectionDate of Approval: April 4, 2003 Iprivask (desirudin) is a specific inhibitor of human thrombin indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism, in patients undergoing elective hip replacement surgery. |
| April 4 |
Factive (gemifloxacin) TabletsDate of Approval: April 4, 2003 Factive (gemifloxacin) is a fluoroquinolone antibiotics indicated for the treatment of community-acquired pneumonia and acute bacterial exacerbation of chronic bronchitis. |
| April 15 |
Vigamox (moxifloxacin) Ophthalmic SolutionDate of Approval: April 15, 2003 Vigamox (moxifloxacin) is a fourth generation fluoroquinilone antibiotic indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of bacteria. |
| April 24 |
Fabrazyme (agalsidase beta)Date of Approval: April 24, 2003 Fabrazyme (agalsidase beta) is a recombinant form of human alpha-galactosidase A, administered intravenously for the treatment of Fabry Disease. |
| April 30 |
Aldurazyme (laronidase)Date of Approval: April 30, 2003 Aldurazyme (laronidase) is recombinant human alpha-L-iduronidaseis indicated for the treatment of mucopolysaccharidosis I (MPS I). |
